With the understanding provided by the study that its the same mechanism that drives patients from mild/ moderate to severe, a reasonable conclusion is that lero will be as effective in keeping mild/moderate patients from becoming severe.

I can't see how lero doesn't become the standard care option regardless/in addition to other drugs used to improve on other aspects of this disease.